指南与共识甲状腺疾病

循证指南是否反映在临床实践中?意大利甲状腺癌观察站前瞻性收集数据的分析

Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory.
指南 / 共识 · Thyroid · 2017-11-10

该研究基于意大利甲状腺癌观察站前瞻性收集的1748例分化型甲状腺癌患者数据,评估意大利初始治疗与2009年美国甲状腺协会(ATA)指南的符合程度。结果显示,甲状腺叶切除术在≤1 cm单灶腺内肿瘤中使用不足,而放射性碘残余消融在多灶≤1 cm肿瘤中仍被频繁使用;风险分层与放射性碘残余消融的使用总体一致。

要点

  • 在≤1 cm单灶腺内分化型甲状腺癌中,甲状腺叶切除术使用不足。
  • 放射性碘残余消融的使用总体与2009年ATA指南风险分层推荐一致。
  • 多灶≤1 cm分化型甲状腺癌中放射性碘残余消融仍被频繁使用,尽管缺乏获益证据。

核心结论

  • 意大利分化型甲状腺癌的治疗方法与2009年ATA指南推荐存在不一致之处。
  • 意大利实践的特点是对≤1 cm单灶腺内分化型甲状腺癌的甲状腺叶切除术使用不足。
  • 放射性碘残余消融的使用总体与风险分层推荐一致,但在多灶≤1 cm分化型甲状腺癌中仍被频繁使用,尽管缺乏获益证据。
  • 这些数据为未来评估国际指南对意大利分化型甲状腺癌管理的影响提供了基线。
  • 研究结果表明,指南推荐的传播与实施以及实践模式的改变需要持续教育和时间。

研究设计与样本

  • 意大利甲状腺癌观察站前瞻性收集参与中心连续诊断的甲状腺癌数据,参与中心均匀分布于全国。
  • 分析数据库自2013年1月1日创建至2016年1月31日期间所有病理确诊的分化型甲状腺癌病例的初始治疗数据。
  • 共纳入1748例患者,其中女性77.2%,中位年龄48.1岁(范围10-85岁)。

主要发现

  • 1640例(93.8%)为乳头状癌(包括84例低分化/侵袭性变异型),108例(6.2%)为滤泡状和Hürthle细胞癌。
  • 中位肿瘤直径为11 mm(范围1-93 mm),多灶肿瘤613例(35%),甲状腺外侵犯492例(28%)。
  • 初始治疗包括全甲状腺切除术(涉及一次或两次手术;n=726;98.8%)和腺叶切除术(n=22;1.2%)。
  • 接受全甲状腺切除术的患者中,408例(23.6%)为单灶、腺内≤1 cm肿瘤。
  • 颈部清扫在40.4%的患者中进行(29.5%行中央区清扫)。

关键数值与推荐

  • 在接受全甲状腺切除术的1726例患者中,1057例(61.2%)行放射性碘残余消融。
  • 按2009年ATA指南标准分类为低风险的患者中,983例中460例(41.2%)行放射性碘残余消融。
  • 按2009年ATA指南标准分类为中风险的患者中,655例中570例(87.1%)行放射性碘残余消融。
  • 按2009年ATA指南标准分类为高风险的患者中,88例中82例(93.1%)行放射性碘残余消融(p < 0.001)。
  • 多灶≤1 cm分化型甲状腺癌病例中,44%行放射性碘残余消融。

临床怎么用

  • 原文未据此给出推荐。
  • 研究结论指出,意大利分化型甲状腺癌的治疗方法与2009年ATA指南推荐存在不一致之处。
  • 研究结论指出,指南推荐的传播与实施以及实践模式的改变需要持续教育和时间。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The goal of evidence-based practice guidelines is to optimize the management of emerging diseases, such as differentiated thyroid cancer (DTC). The aim of this study was to assess therapeutic approaches for DTC in Italy and to see how closely these practices conformed to those recommended in the 2009 American Thyroid Association (ATA) guidelines. METHODS: The Italian Thyroid Cancer Observatory was established to collect data prospectively on thyroid cancers consecutively diagnosed in participating centers (uniformly distributed across the nation). Data on the initial treatment of all pathologically confirmed DTC cases present in the database from January 1, 2013 (database creation) to January 31, 2016, were analyzed. RESULTS: A total of 1748 patients (77.2% females; median age 48.1 years [range 10-85 years]) were enrolled in the study. Most (n = 1640; 93.8%) were papillary carcinomas (including 84 poorly differentiated/aggressive variants); 6.2% (n = 108) were follicular and Hürthle cell carcinomas. The median tumor diameter was 11 mm (range 1-93 mm). Tumors were multifocal in 613 (35%) and presented extrathyroidal extension in 492 (28%) cases. Initial treatments included total thyroidectomy (involving one or two procedures; n = 726; 98.8%) and lobectomy (n = 22; 1.2%). A quarter of the patients who underwent total thyroidectomy had unifocal, intrathyroidal tumors ≤1 cm (n = 408; 23.6%). Neck dissection was performed in 40.4% of the patients (29.5% had central compartment dissection). Radioiodine remnant ablation (RRA) was performed in 1057 (61.2%) of the 1726 patients who underwent total thyroidectomy: 460 (41.2%) of the 983 classified by 2009 ATA guideline criteria as low-risk, 570 (87.1%) of the 655 as intermediate-risk, and 82 (93.1%) of the 88 as high-risk patients (p < 0.001). RRA was performed in 44% of the cases involving multifocal DTCs measuring ≤1 cm. CONCLUSIONS: The treatment approaches for DTCs used in Italy display areas of inconsistency with those recommended by the 2009 ATA guidelines. Italian practices were characterized by underuse of thyroid lobectomy in intrathyroidal, unifocal DTCs ≤1 cm. The use of RRA was generally consistent with risk-stratified recommendations. However, its frequent use in small DTCs (≤1 cm) that are multifocal persists, despite the lack of evidence of benefit. These data provide a baseline for future assessments of the impact of international guidelines on DTC management in Italy. These findings also illustrate that the dissemination and implementation of guideline recommendations, and the change in practice patterns, require ongoing education and time.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Lamartina L, Durante C, Lucisano G, et al. Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory. Thyroid. 2017. PMID: 29020892. doi:10.1089/thy.2017.0299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。